These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture. McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946 [TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. Marini RP; Fox JG; Taylor NS; Yan L; McColm AA; Williamson R Am J Vet Res; 1999 Oct; 60(10):1280-6. PubMed ID: 10791942 [TBL] [Abstract][Full Text] [Related]
4. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection. Ciociola AA; Webb DD; Heath A; Walsh JH Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287 [TBL] [Abstract][Full Text] [Related]
5. Gastric pharmacological activities of tripotassium dicitrato bismuthate in rats and dogs. Soldani G; Del Tacca M; Bernardini C; Polloni A; Martinotti E; Malandrino S; Borsa M; Tonon GC Pharmacol Res Commun; 1985 Nov; 17(11):1017-26. PubMed ID: 3937162 [TBL] [Abstract][Full Text] [Related]
6. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Koo J; Ho J; Lam SK; Wong J; Ong GB Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908 [TBL] [Abstract][Full Text] [Related]
7. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Scheen AJ Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB). Lacey LF; Frazer NM; Keene ON; Smith JT Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806 [TBL] [Abstract][Full Text] [Related]
9. The effect of tripotassium dicitrato bismuthate on the rat stomach. Waldum HL; Qvigstad G; Mårvik R; Brenna E; Syversen U; Sandvik AK Aliment Pharmacol Ther; 1994 Aug; 8(4):425-31. PubMed ID: 7527257 [TBL] [Abstract][Full Text] [Related]
10. Gastric persorption of bismuth from ranitidine bismuth citrate. Fraser AG; Lewin JF; Pounder RE Aliment Pharmacol Ther; 1995 Aug; 9(4):447-50. PubMed ID: 8527622 [TBL] [Abstract][Full Text] [Related]
11. The actions of bismuth in the treatment of Helicobacter pylori infection. Lambert JR; Midolo P Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788 [TBL] [Abstract][Full Text] [Related]
12. The effect of tripotassium dicitrato bismuthate on pepsin activity. De Beaux AC; Defize J; Hunt RH Aliment Pharmacol Ther; 1989 Aug; 3(4):381-5. PubMed ID: 2518852 [TBL] [Abstract][Full Text] [Related]
13. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates. Alarcón T; Domingo D; Prieto N; López-Brea M Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317 [TBL] [Abstract][Full Text] [Related]
15. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947 [TBL] [Abstract][Full Text] [Related]
16. Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis. Ottlecz A; Romero JJ; Lichtenberger LM Aliment Pharmacol Ther; 1999 Jul; 13(7):875-81. PubMed ID: 10383521 [TBL] [Abstract][Full Text] [Related]
17. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Hamilton I; Worsley BW; O'Connor HJ; Axon AT Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964 [TBL] [Abstract][Full Text] [Related]
18. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate. Treiber G; Walker S; Klotz U Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori: treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate. Weil J; Bell GD; Powell K; Morden A; Harrison G; Gant PW; Trowell JE; Burridge S Aliment Pharmacol Ther; 1991 Oct; 5(5):543-7. PubMed ID: 1793785 [TBL] [Abstract][Full Text] [Related]
20. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer. Vondracek TG Ann Pharmacother; 1998 Jun; 32(6):672-9. PubMed ID: 9640487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]